Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hexvix Blue Light vs White Light Cystoscopy in Bladder Cancer
NCT05600322Phase 3Completed
- Sponsor
- Photocure
- Start
- Nov 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hexaminolevulinate in bladder cancer, sponsored by Photocure. Started Nov 2022; status: completed.
02
Drugs
hexaminolevulinate
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT05600322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05600322.